On the Origin of C60 Fullerene Solubility in Aqueous Solution YI Prylutskyy, VI Petrenko, OI Ivankov, OA Kyzyma, LA Bulavin, OO Litsis, ... Langmuir 30 (14), 3967-3970, 2014 | 152 | 2014 |
Structural Features of Highly Stable Reproducible C60 Fullerene Aqueous Colloid Solution Probed by Various Techniques U Ritter, YI Prylutskyy, MP Evstigneev, NA Davidenko, VV Cherepanov, ... Fullerenes, Nanotubes and Carbon Nanostructures 23 (6), 530-534, 2015 | 138 | 2015 |
Anti‐oxidant Properties of C60 Fullerenes in vitro SV Prylutska, II Grynyuk, OP Matyshevska, YI Prylutskyy, U Ritter, ... Fullerenes, Nanotubes and Carbon Nanostructures 16 (5-6), 698-705, 2008 | 134 | 2008 |
Radiation damage to multi-walled carbon nanotubes and their Raman vibrational modes U Ritter, P Scharff, C Siegmund, OP Dmytrenko, NP Kulish, YI Prylutskyy, ... Carbon 44 (13), 2694-2700, 2006 | 132 | 2006 |
Magnetic anisotropy of the graphite nanoplatelet–epoxy and MWCNT–epoxy composites with aligned barium ferrite filler OS Yakovenko, LY Matzui, LL Vovchenko, AV Trukhanov, IS Kazakevich, ... Journal of Materials Science 52 (9), 5345-5358, 2017 | 130 | 2017 |
Application of C60 fullerene-doxorubicin complex for tumor cell treatment in vitro and in vivo RR Panchuk, SV Prylutska, VV Chumak, NR Skorokhyd, LV Lehka, ... Journal of biomedical nanotechnology 11 (7), 1139-1152, 2015 | 129 | 2015 |
C 60 fullerene aggregation in aqueous solution YI Prylutskyy, AS Buchelnikov, DP Voronin, VV Kostjukov, U Ritter, ... Physical Chemistry Chemical Physics 15 (23), 9351-9360, 2013 | 119 | 2013 |
Complexation of C60 Fullerene with Aromatic Drugs MP Evstigneev, AS Buchelnikov, DP Voronin, YV Rubin, LF Belous, ... ChemPhysChem 14 (3), 568-578, 2013 | 116 | 2013 |
C60 Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment S Prylutska, I Grynyuk, O Matyshevska, Y Prylutskyy, M Evstigneev, ... Drugs in R&D 14 (4), 333-340, 2014 | 102 | 2014 |
Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane S Prylutska, R Bilyy, M Overchuk, A Bychko, K Andreichenko, R Stoika, ... Journal of biomedical nanotechnology 8 (3), 522-527, 2012 | 102 | 2012 |
Using water-soluble C60 fullerenes in anticancer therapy SV Prylutska, AP Burlaka, PP Klymenko, II Grynyuk, YI Prylutskyy, ... Cancer nanotechnology 2 (1-6), 105-110, 2011 | 98 | 2011 |
Pristine C60 fullerenes inhibit the rate of tumor growth and metastasis SV Prylutska, AP Burlaka, YI Prylutskyy, U Ritter, P Scharff Exp Oncol 33 (3), 162-164, 2011 | 95 | 2011 |
Electrochemical analysis of ascorbic acid, dopamine, and uric acid on nobel metal modified nitrogen-doped carbon nanotubes NG Tsierkezos, SH Othman, U Ritter, L Hafermann, A Knauer, JM Köhler, ... Sensors and Actuators B: Chemical 231, 218-229, 2016 | 94 | 2016 |
C60 fullerene enhances cisplatin anticancer activity and overcomes tumor cell drug resistance S Prylutska, R Panchuk, G Gołuński, L Skivka, Y Prylutskyy, V Hurmach, ... Nano Research 10 (2), 652-671, 2017 | 92 | 2017 |
Complex of C 60 fullerene with doxorubicin as a promising agent in antitumor therapy SV Prylutska, LM Skivka, GV Didenko, YI Prylutskyy, MP Evstigneev, ... Nanoscale research letters 10 (1), 499, 2015 | 84 | 2015 |
Comparative study of biological action of fullerenes C60 and carbon nanotubes in thymus cells SV Prylutska, II Grynyuk, SM Grebinyk, OP Matyshevska, YI Prylutskyy, ... Materialwissenschaft und Werkstofftechnik: Entwicklung, Fertigung, Prüfung …, 2009 | 83 | 2009 |
Study of C60 fullerenes and C60-containing composites cytotoxicity in vitro SV Prylutska, OP Matyshevska, AA Golub, YI Prylutskyy, GP Potebnya, ... Materials Science and Engineering: C 27 (5-8), 1121-1124, 2007 | 82 | 2007 |
Fullerene C60 Penetration into Leukemic Cells and Its Photoinduced Cytotoxic Effects D Franskevych, K Palyvoda, D Petukhov, S Prylutska, I Grynyuk, ... Nanoscale research letters 12 (1), 40, 2017 | 80 | 2017 |
Hyperthermic effect of multi-walled carbon nanotubes stimulated with near infrared irradiation for anticancer therapy: in vitro studies A Burlaka, S Lukin, S Prylutska, O Remeniak, Y Prylutskyy, M Shuba, ... Experimental Oncology, 2010 | 79 | 2010 |
C60 Fullerene Prevents Restraint Stress-Induced Oxidative Disorders in Rat Tissues: Possible Involvement of the Nrf2/ARE-Antioxidant Pathway OO Gonchar, AV Maznychenko, NV Bulgakova, IV Vereshchaka, ... Oxidative Medicine and Cellular Longevity 2018, 2018 | 76 | 2018 |